RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
종목 코드 RXST
회사 이름Rxsight Inc
상장일Jul 30, 2021
CEODr. Ron M. Kurtz, M.D.
직원 수498
유형Ordinary Share
회계 연도 종료Jul 30
주소100 Columbia Street
도시ALISO VIEJO
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호92656
전화19495217822
웹사이트https://www.rxsight.com/
종목 코드 RXST
상장일Jul 30, 2021
CEODr. Ron M. Kurtz, M.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음